From Lab to Life. How Digital Production of Medicines could finally reach the patient – Presented by Tobias Gantner, HealthCare Futurists

From Lab to Life. How Digital Production of Medicines could finally reach the patient – Presented by Tobias Gantner, HealthCare Futurists, at the 3D Medical Conference 2018, which will take place on 30-31 January 2018 at MECC Maastricht, The Netherlands. Digital Production of Medicines is already quite advanced. The bigger hurdle is to take the… [read more]

3D Medical Conference welcomes ECHAlliance as Media Partner

3D Medical Conference welcomes ECHAlliance as Media Partner About ECHAlliance The ECHAlliance is a Community Interest Company (CIC) registered in Belfast – Northern Ireland (UK). We are a not-for-profit organisation. Facilitating international multi-stakeholder connections around ecosystems, driving sustainable change and disruption in the delivery of health and social care.

3D Medical Conference welcomes 3DPrinting as Media Partner

3D Medical Conference welcomes 3DPrinting as Media Partner About 3DPrinting Launched in September 2015 by multimedia journalist Laura Loenert, 3DPrinting proposes to provide relevant and free content in text, photo and video formats involving 3D printing, robotics, open hardware and drones, among other related topics. Our mission is to become a reference for the Brazilian… [read more]

Utrecht3DMedical – 3D Bioprinting Lab in Utrecht

The city of Utrecht in Netherland is already famous for the outstanding achievements made by the tissue factory subordinated to the University Medical Center Utrecht to a great extent. This tissue factory has recently accomplished the 3D bioprinted rabbit shoulder implantation experiment. Now, this city is attracting more biologic printing institutions. With the cooperation of the University Medical… [read more]

Research Proves Superiority of 3D Bioprinted Human Liver Tissues in Assessing Drug-Induced Toxicity

Organovo Holdings, Inc., a three-dimensional biology company focused on delivering scientific and medical breakthroughs using its 3D bioprinting technology, today announced a publication in the scientific journal, PLOS One, which demonstrates the superiority of Organovo’s 3D bioprinted human liver tissues to effectively model drug-induced liver injury and distinguish between highly-related compounds with different toxicity profiles.